BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 38686795)

  • 1. Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.
    Wu R; Nie Q; Tapper EE; Jerde CR; Dunlap GS; Shrestha S; Elraiyah TA; Offer SM; Diasio RB
    Cancer Res; 2016 Nov; 76(21):6362-6373. PubMed ID: 27578004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dihydropyrimidine dehydrogenase activity and its genetic aberrations].
    Ogura K
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1041-8. PubMed ID: 16912518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline
    Zhang T; Ambrodji A; Huang H; Bouchonville KJ; Etheridge AS; Schmidt RE; Bembenek BM; Temesgen ZB; Wang Z; Innocenti F; Stroka D; Diasio RB; Largiadèr CR; Offer SM
    Elife; 2024 Apr; 13():. PubMed ID: 38686795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline
    Zhang T; Ambrodji A; Huang H; Bouchonville KJ; Etheridge AS; Schmidt RE; Bembenek BM; Temesgen ZB; Wang Z; Innocenti F; Stroka D; Diasio RB; Largiadèr CR; Offer SM
    bioRxiv; 2024 Mar; ():. PubMed ID: 37961517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
    Noguchi T; Tanimoto K; Shimokuni T; Ukon K; Tsujimoto H; Fukushima M; Noguchi T; Kawahara K; Hiyama K; Nishiyama M
    Clin Cancer Res; 2004 Oct; 10(20):7100-7. PubMed ID: 15501990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in Chinese cancer patients.
    He YF; Wei W; Zhang X; Li YH; Li S; Wang FH; Lin XB; Li ZM; Zhang DS; Huang HQ; Hu B; Jiang WQ
    J Clin Pharm Ther; 2008 Jun; 33(3):307-14. PubMed ID: 18452418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines.
    Omura K
    Int J Clin Oncol; 2003 Jun; 8(3):132-8. PubMed ID: 12851836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Characterization of 21 Allelic Variants of Dihydropyrimidine Dehydrogenase Identified in 1070 Japanese Individuals.
    Hishinuma E; Narita Y; Saito S; Maekawa M; Akai F; Nakanishi Y; Yasuda J; Nagasaki M; Yamamoto M; Yamaguchi H; Mano N; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2018 Aug; 46(8):1083-1090. PubMed ID: 29769267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoropyrimidine-associated toxicity and DPYD variants c.85T>C, c.496A>G, and c.1236G>A: impact of haplotype.
    Medwid S; Wigle TJ; Kim RB
    Cancer Chemother Pharmacol; 2023 Jan; 91(1):97-102. PubMed ID: 36357798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for cell type specific DNA binding of C/EBPβ: The case of cell cycle inhibitor p15INK4b promoter.
    Lountos GT; Cherry S; Tropea JE; Wlodawer A; Miller M
    J Struct Biol; 2022 Dec; 214(4):107918. PubMed ID: 36343842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typical Enhancers, Super-Enhancers, and Cancers.
    Koutsi MA; Pouliou M; Champezou L; Vatsellas G; Giannopoulou AI; Piperi C; Agelopoulos M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.
    Castro-Mondragon JA; Riudavets-Puig R; Rauluseviciute I; Lemma RB; Turchi L; Blanc-Mathieu R; Lucas J; Boddie P; Khan A; Manosalva Pérez N; Fornes O; Leung TY; Aguirre A; Hammal F; Schmelter D; Baranasic D; Ballester B; Sandelin A; Lenhard B; Vandepoele K; Wasserman WW; Parcy F; Mathelier A
    Nucleic Acids Res; 2022 Jan; 50(D1):D165-D173. PubMed ID: 34850907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ReMap 2022: a database of Human, Mouse, Drosophila and Arabidopsis regulatory regions from an integrative analysis of DNA-binding sequencing experiments.
    Hammal F; de Langen P; Bergon A; Lopez F; Ballester B
    Nucleic Acids Res; 2022 Jan; 50(D1):D316-D325. PubMed ID: 34751401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them.
    Ramos A; Sadeghi S; Tabatabaeian H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502361
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.